CERN 63.01 Cerner Corp $CERN Hit a 52 week high of 63.96

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
CERN 63.01 Cerner Corp $CERN Hit a 52 week high of 63.96 Currently at 63.01 -0.87 -1.36% With a day low of 62.70 and a total volume of 1,695,800.

CERN Cerner Corp Recent Headline News

Cognizant CFO Karen McLaughlin Says Health Care, the Cloud Are Key to Growth
at The Street - Wed Nov 05, 12:10PM CST
Cognizant beat predictions on earnings, but now faces the challenge of becoming a major player in health care IT.
MCK: 199.32 (-3.34), WDAY: 94.56 (-0.43), CTSH: 53.62 (+0.98), HNT: 47.01 (-1.08), CERN: 63.01 (-0.87), CRM: 63.97 (+0.88)

Insider Trading Alert - CERN, MJN And AL Traded By Insiders
at The Street - Wed Nov 05, 11:25AM CST
Stocks with insider trader activity include CERN, MJN and AL
MJN: 98.39 (-0.45), AL: 37.60 (+0.09), CERN: 63.01 (-0.87)

Cerner and Livongo Announce Agreement to Help Health Care Providers and Patients Better Manage Diabetes
GlobeNewswire - Mon Nov 03, 7:38AM CST
Cerner Corp. (CERN) today announced a multi-year agreement with Livongo Health(TM) to connect diabetes screening data collected from "smart" consumer devices with Cerner health care clients. For people with diabetes, this can mean more effective self-management and a better use of time with their clinician. For care teams, this provides near real-time access to patient information, enabling quick interventions when a patient might be headed toward trouble.
CERN: 63.01 (-0.87)

Cerner to Present Comprehensive Preventive Care Solutions at Cerner Health Conference
GlobeNewswire - Fri Oct 31, 5:12PM CDT
Cerner Corporation (Nasdaq:CERN) today announced it will present its Preventive Care Advisor solution during the Cerner Health Conference (CHC) next week in Kansas City. The solution delivers real-time lists of eligible Medicare-approved preventive screenings, which can help improve care and overall patient wellness.
CERN: 63.01 (-0.87)

MedStar Health Signs Expanded Agreement With Cerner
GlobeNewswire - Thu Oct 30, 2:00PM CDT
MedStar Health, the largest healthcare provider in Maryland and the Washington, D.C. region, and Cerner (Nasdaq:CERN) today announced an expanded partnership with a seven-year agreement that will streamline operations, help improve the quality of patient care and develop technologies that align with MedStar's vision to be the trusted leader in caring for people and advancing health.
CERN: 63.01 (-0.87)

Alere (ALR) Lags Q3 Earnings, Revenues; Outlook Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 12:40PM CDT
Alere Inc. (ALR) reported disappointing third-quarter 2014 results as both the top and the bottom line missed the Zacks Consensus Estimate by a wide margin
BIO: 110.60 (-0.50), ALR: 39.37 (-0.70), CERN: 63.01 (-0.87), ATHN: 123.82 (-1.94)

Truven Health Analytics and Cerner Partner to Make Micromedex Integrated CareNotes Available to Cerner EHR Clients
Business Wire - Wed Oct 29, 7:02AM CDT
Truven Health Analytics(TM) today announced an agreement with Cerner Corporation, a leading provider of health information and electronic health record (EHR) systems, to resell its Micromedex(R) CareNotes(R) product, a part of the Patient Connect Suite of patient and consumer education and engagement solutions. The evidence-based, health literacy standardized resources in CareNotes will be accessible directly from Cerner's EHR by clinicians in Acute Care and Ambulatory facilities and will include resources for the Emergency Department, Inpatient Discharge Instructions, General Health Summaries, Pre-care, Inpatient, Laboratory and Medication Education, among other tools and content, in multiple languages.
CERN: 63.01 (-0.87)

McKesson's Acquisition Powers Drug Revenue Higher
Todd Campbell, The Motley Fool - Motley Fool - Tue Oct 28, 6:14PM CDT
Source: McKesson. McKesson is one of the planet's biggest drug distributors. The company is responsible for delivering roughly one out of every three prescription drugs used in the United States daily and generates more than $138 billion in...
MCK: 199.32 (-3.34), CERN: 63.01 (-0.87)

Global Pharmacy Automation Systems Market Forecasts and Opportunities, 2019 - Analysis of the $4.1 Billion Industry
M2 - Tue Oct 28, 6:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zh84wk/pharmacy) has announced the addition of the "Pharmacy Automation Systems Market by product type & by End-user - Global Forecasts & Trends to 2019" report to their offering. The pharmacy automation market is expected to reach $4.5 billion by 2019 from $3.1 billion in 2014 The global pharmacy automation systems market has witnessed considerable growth over the past few years and is further expected to grow In this report the market is segmented by product, end user, and by geography. On the basis of product, the market includes automated medication dispensing systems, automated packaging and labeling systems, automated medication compounding systems, storage and retrieval systems, table-top counters, and other systems. Whereas, on the basis of end users, the market includes the inpatient pharmacy units, outpatient pharmacy units, retail pharmacies, and pharmacy benefit management organizations and other mail-order setting. The inpatient pharmacy automation market is further classified as acute care setting and long-term care setting, while the outpatient pharmacy automation market is segmented into fast-track clinics and hospital pharmacies. Factors such as the necessity of cost containment, reduction of medication errors, and the need to increase the efficiency of work within the pharmacies are the major drivers for the pharmacy automation systems market. However, stringent regulatory guidelines which delay product launches, high costs of implementation of automation systems, and restricted budgets of healthcare that lower investments in the automated systems by small companies are some of the key factors restraining the growth of the global market. However, the increasing awareness regarding the benefits of the pharmacy automation systems in the developing countries offer new growth opportunities to the market players. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Pharmacy Automation Systems Market, By Product 5 Global Pharmacy Automation Systems Market, By End-Users 6 Global Pharmacy Automation Systems Market, By Geography 7 Competitive Landscape 8 Company Profiles - Baxter International Inc. - Carefusion Corporation - Cerner Corporation - Kirby Lester - Mckesson Corporation - Omnicell, Inc. - Parata Systems Llc - Scriptpro Llc - Swisslog Holding Ag - Talyst, Inc. For more information visit http://www.researchandmarkets.com/research/zh84wk/pharmacy
BAX: 70.61 (-0.99), OMCL: 31.89 (-0.28), CERN: 63.01 (-0.87)

Brother Mobile Solutions to Showcase its Cerner Certified Patient ID Printers at the Cerner Health Conference (CHC) 2014
Business Wire - Tue Oct 28, 6:02AM CDT
Brother Mobile Solutions, Inc. (BMS) a wholly-owned subsidiary of Brother International Corporation and premier provider of mobile and desktop thermal printing products, announces that it will showcase its Cerner-certified TrustSense(TM) healthcare patient ID printing solution at the Cerner Health Conference 2014, November 2-5 in Kansas City, Missouri. Developed in partnership with PDC Healthcare, the mobile solution provides on-demand wristband and label printing virtually anywhere in the hospital.
CERN: 63.01 (-0.87)

How Obamacare Could Save Taxpayers $17 Billion
Todd Campbell, The Motley Fool - Motley Fool - Sun Oct 26, 12:31PM CDT
Source: 401kcalculator.org via Fickr. Obamacare has its work cut out for it. Healthcare spending in the U.S. totals about $3 trillion annually, and growing expenses tied to caring for ageing baby boomers has industry watchers expecting that...
CERN: 63.01 (-0.87)

Cerner (CERN) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Fri Oct 24, 9:17PM CDT
The following Cerner (CERN) conference call took place on October 23, 2014, 04:30 PM ET. This is a transcript of that earnings call:
CERN: 63.01 (-0.87)

Cerner Set to Possibly Pullback After Yesterday's Rally of 2.38%
Comtex SmarTrend(R) - Fri Oct 24, 5:29PM CDT
Cerner (NASDAQ:CERN) traded in a range yesterday that spanned from a low of $59.16 to a high of $61.17. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $60.28 on volume of 2.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CERN: 63.01 (-0.87)

After Yesterday's Rally of 2.38% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Oct 24, 5:29PM CDT
Cerner (NASDAQ:CERN) traded in a range yesterday that spanned from a low of $59.16 to a high of $61.17. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $60.28 on volume of 2.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CERN: 63.01 (-0.87)

Stocks Cling To Decent Gains; Alibaba Nears High
at Investor's Business Daily - Fri Oct 24, 12:25PM CDT
Stocks came off session highs midday Friday as the major indexes looked to finish the week with big gains. Blue chips led, with the Dow Jones industrial average up 0.4%. Twenty-five of the 30 Dow stocks were higher at midday, led by Proctor & Gamble...
MMM: 156.55 (+0.50), PFE: 29.92 (-0.12), PG: 89.13 (+0.23), MSFT: 48.68 (-0.02), AAPL: 109.01 (+0.31), CERN: 63.01 (-0.87), BABA: 114.56 (+2.99)

Cerner Sees In-Line Q3 Earnings but Revenues Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:50AM CDT
For the fourth quarter of 2014, Cerner Corporation (CERN) anticipates revenues between $880 and $915 million
QSII: 14.56 (-0.34), MDRX: 11.54 (-2.01), CERN: 63.01 (-0.87), ATHN: 123.82 (-1.94)

CERNER
at Investor's Business Daily - Thu Oct 23, 5:56PM CDT
CERNER (CERN), a health-info tech firm, said its Q3 EPS rose 20% to 42 cents, in line, and sales rose 15.4% to $840.1 mil, missing. Shares fell 2.1% to 58.46.
CERN: 63.01 (-0.87)

Cerner meets 3Q profit forecasts
Automated Insights - Thu Oct 23, 3:21PM CDT
KANSAS CITY, Mo. (AP) _ Cerner Corp. (CERN) on Thursday reported third-quarter profit of $129 million.
CERN: 63.01 (-0.87)

Cerner Reports Third Quarter 2014 Results
GlobeNewswire - Thu Oct 23, 3:02PM CDT
Cerner Corporation (Nasdaq:CERN) today announced results for the 2014 third quarter that ended September 27, 2014, delivering strong levels of bookings, revenue, earnings and cash flow.
CERN: 63.01 (-0.87)

Nascent Rally Gains Traction; Caterpillar, 3M Boost Dow
at Investor's Business Daily - Thu Oct 23, 1:58PM CDT
Major averages showed broad gains and were near session highs with a little more than one hour remaining in Wednesday's session. The Nasdaq jumped 2.1% and the S&P 500 and Dow Jones industrial average gained 1.8% each. The Dow was helped by strong...
AMZN: 299.86 (+3.22), LCI: 50.17 (-0.82), MMM: 156.55 (+0.50), AAP: 141.85 (-3.71), ORLY: 179.00 (-0.61), CAT: 101.76 (+0.85), EPAM: 46.95 (-0.97), CERN: 63.01 (-0.87)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 250

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 254

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 353

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 155

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 143

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 313

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Total Voting Rights: A Crucial Overview

Updated Category News Views 192

Insights into Total Voting Rights and Capital Octopus AIM VCT plc is a company that regularly updates its shareholders regarding vital information, including total voting rights and capital structure. Current Share Capital Details As of the latest disclosure period, Octopus AIM VCT plc has an issued share capital comprising 223,655,160 Ordinary shares, each valued at 1...

Continue Reading
Understanding Market Sentiment for Bio-Techne's Stock

Updated Category News Views 130

Analyzing Bio-Techne's Market Position Bio-Techne (NYSE: TECH) has recently seen an increase in the short percent of float, now standing at 29.12% since its last report. This translates to approximately 5.08 million shares sold short, making up 3.68% of all available regular shares for trading. With the current trading volume, it would typically take about 2.66 days for...

Continue Reading
Innovative Developments in Wound Care by Kane Biotech Inc.

Updated Category News Views 120

Advancements in Wound Care from Kane Biotech Inc. WINNIPEG, Manitoba — Kane Biotech Inc. (TSX-V:KNE) is making headlines with groundbreaking clinical and scientific advancements in wound care. The company recently showcased its innovative data during the Innovations in Wound Healing Annual Meeting, an event dedicated to revolutionizing treatment in this critical field....

Continue Reading
Senior Helpers Achieves Recognition as a Leading Franchise

Updated Category News Views 178

Senior Helpers Achieves Recognition as a Leading Franchise Independent Survey Shows Franchise Owners Are Highly Satisfied with Senior Helpers' Support and Overall Performance Senior Helpers has recently been awarded the title of a Top Franchise for 2025 by Franchise Business Review (FBR). This year marks a significant milestone as it is FBR's 20th year of recognizing...

Continue Reading
Bearish Moves: What Big Players Think of Super Micro Computer

Updated Category News Views 232

Diving into Super Micro Computer's Options Landscape You gotta love this market, right? Sometimes it’s a real gut check, and right now, Super Micro Computer (NASDAQ:SMCI) is at the forefront of some, let’s say, interesting options activity. Financial giants are making bearish moves—like, big-time bearish. Our look into the options history for good ol' SMCI shook out...

Continue Reading